Immuron Travelan® sales continued strong growth
10 avr. 2024 06h00 HE
|
Immuron Limited
Sales Highlights: Global FYTD Mar 2024 AUD$3.6 million up 154% on (prior comparative period) pcpMar 2024 Quarter AUD$1.3 million up 51% on pcp and 75% on last quarter ...
Immuron achieves record Travelan® sales
13 févr. 2024 06h00 HE
|
Immuron Limited
Highlights: Travelan® sales YTD Jan 2024 of $2.7 million exceed peak full year FY20 sales of $2.5 millionAustralian Travelan® YTD Jan 2024 sales $2.1 millionUSA Travelan® YTD Jan 2024 sales $0.6...
Immuron achieves record half yearly Travelan® sales
16 janv. 2024 06h00 HE
|
Immuron Limited
Highlights: Record half yearly Travelan® sales of $2,334,969Total sales of A$2,355,580 in H1, FY24 $1,771,932 increase on H1, FY23 sales51% higher than pre-pandemic period H1, FY20 sales ...
Immuron Announces Travelan® Clinical Study Cohort 2 commences
18 oct. 2023 06h00 HE
|
Immuron Limited
Highlights: Second cohort of 34 healthy volunteers enrolled in the Travelan® Clinical Trial Clinical Trial to examine a dosing regimen for Travelan® more suited to the US military has commenced...
Immuron achieves record quarterly Travelan® sales
11 oct. 2023 06h00 HE
|
Immuron Limited
Highlights: Record quarterly Travelan® sales of $1,550,240Total sales of A$1,565,767 in Q1, FY24 $1,508,933 increase on Q1, FY23 sales130% higher than pre-pandemic period Q1, FY20 sales ...
Immuron achieves record monthly Travelan® sales
13 sept. 2023 06h00 HE
|
Immuron Limited
Highlights: Record monthly Travelan® salesAustralian sales of A$1.18 M in August 2023 (7984% increase on August 2022 sales) MELBOURNE, Australia, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Immuron...
Immuron Announces First Patients Enrolled in Travelan® Clinical Study
25 juil. 2023 06h00 HE
|
Immuron Limited
Highlights: First cohort of 30 healthy volunteers enrolled in the Travelan® Clinical Trial Clinical Trial to examine a dosing regimen for Travelan® more suited to the US military has commenced...
Immuron FY23 Sales increase 136% on FY22 Sales
05 juil. 2023 06h00 HE
|
Immuron Limited
Highlights: Australian FY23 sales of A$1.16 M (478% increase on FY22 sales)USA FY23 Travelan® sales of A$643 k (28% increase on FY22 sales)Global FY23 sales of A$1.80 M (136% increase on FY22 sales) ...
Immuron Business Update: Letter to Shareholders
22 juin 2023 06h00 HE
|
Immuron Limited
Highlights: Immuron Board approves IMM-529 cGMP manufacturing and to proceed with FDA pre-IND submissionRecruitment and screening update for Travelan® Controlled Human Infection Model (CHIM)...
Immuron Initiates Recruitment of Travelan® Clinical Study
30 mai 2023 06h00 HE
|
Immuron Limited
Highlights: Immuron receives approval from U.S. Army Medical Research and Development CommandRecruitment and screening of healthy volunteers for Travelan® Controlled Human Infection Model (CHIM)...